Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
8,070.10
-9.10
(-0.11%)
ASX 200
7,822.30
-9.50
(-0.12%)
AUD/USD
0.6752
+0.0024
(+0.35%)
OIL
83.44
-0.44
(-0.52%)
GOLD
2,399.80
+30.40
(+1.28%)
Bitcoin AUD
84,058.80
+2,187.79
(+2.67%)
Xilio Therapeutics, Inc. (XLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8950
+0.0320
(+3.71%)
At close: 04:00PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
55,397
59,201
51,188
43,910
14,256
Selling general and administrative
28,773
29,948
23,856
10,653
4,771
Total operating expenses
84,170
89,149
75,044
54,563
19,027
Operating income or loss
-84,170
-89,149
-75,044
-54,563
-19,027
Total other income/expenses net
2,955
927
-756
-656
1,716
Income before tax
-81,215
-88,222
-75,800
-55,219
-17,311
Income from continuing operations
-81,215
-88,222
-75,800
-55,219
-17,311
Net income
-81,215
-88,222
-75,800
-55,219
-17,311
Net income available to common shareholders
-81,215
-88,222
-75,800
-55,219
-17,311
Basic EPS
-2.96
-3.22
-13.52
-2.07
-0.65
Diluted EPS
-2.96
-3.22
-13.52
-2.07
-0.65
Basic average shares
27,461
27,392
5,606
26,666
26,666
Diluted average shares
27,461
27,392
5,606
26,666
26,666
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.